company

HAMARKLINIKKEN AS

2317 HAMAR

Return on Equity
−7,74 %
Current Ratio
47,6
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 533 000
Net Income−83 000
Total Assets1 087 000
Total Equity1 072 000
Income (NOK)2022
Revenue1 533 000
Expenditure1 635 000
Operating Profit−102 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−102 000
Tax−19 000
Net Income−83 000
Balance (NOK)2022
Total Fixed Assets373 000
Total Current Assets714 000
Total Assets1 087 000
Total Retained Equity−130 000
Total Equity1 072 000
Total Long-Term Debt0
Total Current Debt15 000
Total Equity and Debt1 087 000
Cash flow (NOK)2022
Sales Income1 533 000
Other Income0
Revenue1 533 000
Cost of Goods Sold716 000
Salary Costs0
Depreciation198 000
Impairment0
Expenditure1 635 000
Operating Profit−102 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−83 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures373 000
Total Tangible Assets373 000
Total Fiancial Fixed Assets0
Total Fixed Assets373 000
Stock0
Total Investments0
Cash, Bank374 000
Total Current Assets714 000
Total Assets1 087 000
Total Equity1 072 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors3 000
Unpaid Taxes0
Dividends0
Other Current Debt12 000
Total Current Debt15 000
Total Equity and Debt1 087 000
Financial indicators2022
Return on Equity−7,74 %
Debt-to-Equity Ratio0
Operating Profit Margin−6,65 %
Current Ratio47,6
Quick Ratio47,6
Equity Ratio0,99
Gross Profit Margin53,29 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English